Can This Healthcare Stock Keep Beating the Market?
While the broader market is struggling, Krystal Biotech (NASDAQ: KRYS) is performing relatively well. Shares of the gene-editing specialist are in the green for the year. It's been a volatile ride, though, and there could be more twists and turns for Krystal Biotech in the next 10 months. On the other hand, there are good reasons the biotech might continue to deliver market-beating returns. Should investors bet on Krystal Biotech right now?
Source Fool.com